Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

30. Juni 2016 03:00 ET | Quelle: Veloxis Pharmaceuticals A/S

Veloxis announces the total number of shares and voting rights in the company as of 30 June 2016

Company Announcement no. 15/2016 To: NASDAQ OMX Copenhagen...
28. Juni 2016 22:33 ET | Quelle: Veloxis Pharmaceuticals A/S

Veloxis Receives Envarsus XR® Package Insert Label Enhancements Based on Study of African-American Transplant Recipients

Company Announcement no. 14/2016 To: NASDAQ OMX Copenhagen A/S ...
13. Juni 2016 02:00 ET | Quelle: Veloxis Pharmaceuticals A/S

Veloxis increases share capital in connection with exercise of warrants

Company Announcement no. 13/2016 To: NASDAQ OMX Copenhagen...
08. Juni 2016 09:21 ET | Quelle: Veloxis Pharmaceuticals A/S

Veloxis to Present Company Overview and Envarus® XR (tacrolimus extended-release tablets) Launch Update at Jefferies 2016 Healthcare Conference

Investor service announcement no. 4/2016 To: NASDAQ OMX Copenhagen...
31. Mai 2016 12:00 ET | Quelle: Veloxis Pharmaceuticals A/S

Veloxis announces the total number of shares and voting rights in the company as of 31 May 2016

Company Announcement no. 12/2016 To: NASDAQ OMX Copenhagen...
30. Mai 2016 02:00 ET | Quelle: Veloxis Pharmaceuticals A/S

Veloxis increases share capital in connection with exercise of warrants

Company Announcement no. 11/2016 To: NASDAQ OMX Copenhagen...
19. Mai 2016 14:29 ET | Quelle: Veloxis Pharmaceuticals A/S

Veloxis Pharmaceuticals A/S establishes new Warrant Programme

Company Announcement no. 10/2016 To: NASDAQ Copenhagen...
18. Mai 2016 12:00 ET | Quelle: Veloxis Pharmaceuticals A/S

Veloxis Pharmaceuticals announces financial results for the first three months of 2016

Company Announcement no. 9/2016 To: NASDAQ OMX Copenhagen...
11. Mai 2016 04:00 ET | Quelle: Veloxis Pharmaceuticals A/S

Veloxis Pharmaceuticals A/S to Host Conference Call Announcing Interim Report for the first Quarter 2016 – results from 1 January to 31 March, 2016

Investor service announcement no. 3/2016 To: NASDAQ OMX Copenhagen ...
07. April 2016 13:35 ET | Quelle: Veloxis Pharmaceuticals A/S

Veloxis Pharmaceuticals A/S establishes new Warrant Programme

Company Announcement no. 8/2016 To: NASDAQ Copenhagen...

Vorherige Seite